GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia a

Synonyms

Noun

1. hemophilia A

2. haemophilia A, classical hemophilia, classical haemophilia, hemophilia, haemophilia, bleeder's disease

Usage
Prophylaxis vs. On-Demand Treatment for Hemophilia B - HealthCentral
Hemophilia A treatments may shape children’s immune responses - Hemophilia News Today
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors - The New England Journal of Medicine
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity - Nature
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
Clinical Trial Results Support the Potential of Denecimig in Hemophilia A - Hematology Advisor
B Cells Identified as Potential Drivers of Immune Dysregulation in Acquired Hemophilia A - Pharmacy Times
FDA Expands Marstacimab Indication in Hemophilia A and B - Conexiant
Global Hemophilia Survey Amplifies Patient and Caregiver Voices - Sanofi
Hemophilia B: Symptoms, Causes, and Treatment Options - HealthCentral
Activated factor VIII-mimetic prophylaxis associated with reduced bleeding in hemophilia A - 2 Minute Medicine
FDA grants fast track status to 1-time stem cell therapy for hemophilia A - Hemophilia News Today
Marstacimab sBLA for Expanded Use in Hemophilia A or B Gets Priority Review - Hematology Advisor
Hemophilia B Treatment: Options and Advances - HealthCentral
Lower-dose gene therapy effective in severe hemophilia A: Study - Hemophilia News Today
Study Highlights Sustained Psychosocial Impairment in Inhibitor-Free Hemophilia A - Hematology Advisor
9 Myths and Facts About Hemophilia B - HealthCentral
Altuviiio safe, effective in patients with severe hemophilia A: Study - Hemophilia News Today
Emicizumab Prophylaxis May Be Safe, Effective in Infants With Hemophilia A - Hematology Advisor
Machine learning estimation of FVIII pharmacokinetic parameters in Chinese children with severe Hemophilia A - Nature
Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM - PR Newswire
Denecimig excels at reducing bleeds in hemophilia A patients: Study - Hemophilia News Today
Idiopathic Acquired Hemophilia A With High-Titer Factor VIII Inhibitor in an Elderly Patient: A Case Report - Cureus
Real-world study backs safety of Hemlibra for acquired hemophilia A - Hemophilia News Today
Mim8 Prophylaxis Shows Durable Bleed Control at 52 Weeks in Hemophilia A - Docwire News
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Marstacimab-hncq (Hympavzi) Gains FDA Approval for Expanded Hemophilia A and B Indication in Patients Aged 6 Years and Older - Consultant360
Hemlibra outperforms ITI in controlling bleeding in hemophilia A children - Hemophilia News Today
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi - Fierce Pharma
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
Improving Health-Related Quality of Life for Children With Hemophilia - Hematology Advisor
New deal aims to bring BBM’s hemophilia A gene therapy to China - Hemophilia News Today
FDA Supports Advancement of GENV-HEM Gene Therapy for Hemophilia A - Docwire News
Delayed diagnosis of hemophilia A presenting as chronic joint swelling: a case report - Frontiers
FDA expands Hympavzi approval to more hemophilia patients - Hemophilia News Today
FDA expands marstacimab (HYMPAVZI) approval to children ages 6–11 and hemophilia patients with inhibitors - Contemporary Pediatrics
Refractory Hemorrhage Following Total Knee Replacement Unmasking Acquired Hemophilia A - Cureus
Hemophilia A drug Hemlibra demonstrates long-term safety, sharply cutting exercise-related bleeding risk - koreabiomed.com
3 years on Hemlibra keeps joints healthy in kids with hemophilia A - Hemophilia News Today
Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients - PR Newswire
BASIS Phase 3 Trial: Marstacimab Shows Itself a Versatile Hemophilia A, HB Prophylaxis - Docwire News
Hemophilia Studies Today: Points of Interest - Docwire News
Novo Nordisk Submits FDA Application for Hemophilia A Therapy - Hematology Advisor
EnzySystem for hemophilia A could make home clotting tests easier - Hemophilia News Today
Abstract - 2026 - Haemophilia - Wiley Online Library
New study finds better mental health linked to adherence in hemophilia - Hemophilia News Today
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Hemophilia A Pipeline Gains Momentum: 40+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A - MedPage Today
Real-World Use of Efanesoctocog Alfa Shows Benefit in Severe Hemophilia A - Hematology Advisor
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
BASIS Phase 3 Trial: Marstacimab Shows Itself a Versatile Hemophilia A, HB Prophylaxis - Docwire News
It’s Time to Look Beyond the Bleed - Sanofi
Efanesoctocog Alfa Improves Bleeding Regardless of Age in Hemophilia A, With Lynn Malec, MD, MSc - HCPLive
Michigan man gets new Roctavian gene therapy for hemophilia A - Detroit Free Press
Doctors warn eye bleeding can be first sign of hemophilia A - Hemophilia News Today
Hemophilia Treatment Market Industry Report & Forecast 2035 - Business Research Insights
Use of efanesoctocog alfa in the treatment of hemophilia A - Via Medica Journals
Clinical Scenarios in Hospitalized Patients With Hemophilia - Cureus
Pfizer Reports Patient Death in Long-Term Trial of Hympavzi for Hemophilia A - BioSpace
Playing sports often may raise bleeding risk in boys with hemophilia - Hemophilia News Today
Evolving treatment paradigms in hemophilia: A written recap - Managed Healthcare Executive
Ongoing Trial Investigates Switching from Emicizumab to Fitusiran in Hemophilia A, With Guy Young, MD - HCPLive
Silent Avascular Necrosis of the Femoral Head in Severe Hemophilia A: A Case Report - Cureus
Weekly and Monthly Mim8 Prophylaxis Deliver Durable Bleed Control Across 52 Weeks in Hemophilia A - Hematology Advisor
Novo Nordisk Submits Denecimig (Mim8) BLA for Hemophilia A - HCPLive
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Efanesoctocog Alfa Improves Outcomes for Patients With Hemophilia A - Docwire News
Digital tool could help people with hemophilia ‘live their normal life’ - Hemophilia News Today
Case Report: Coexisting cold agglutinin disease and acquired hemophilia A: a rituximab-responsive dual autoimmune disorder - Frontiers
FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors - Contemporary Pediatrics
Laboratory investigation and clinical management of acquired coagulation factor inhibitors: A joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline - Wiley Online Library
Routine dental work safe in hemophilia patients with clotting factor boost - Hemophilia News Today
Pfizer’s Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors - Contract Pharma
Hemlibra may help active men with hemophilia A stay in the game - Hemophilia News Today
BioMarin pulls hemophilia gene therapy Roctavian, taking $240M hit after divestiture efforts flounder - Fierce Pharma
FRONTIER Trials Support BLA for Investigational Hemophilia A Drug - Docwire News
Study Identifies Determinants of Desmopressin Response in Female Hemophilia A Carriers - Hematology Advisor
Balancing the benefits and risks of rebalancing coagulation in haemophilia - The Lancet
Building safeguards for gene therapy in haemophilia - The Lancet
Novo Nordisk submits Biologics License Application (BLA) to FDA for Mim8; an investigational, prophylaxis treatment for people living with hemophilia A with or without inhibitors - PR Newswire
Hand swelling is first sign of aquired hemophilia A for new mom: Report - Hemophilia News Today
Standard or low-dose rituximab effective for acquired hemophilia A - Hemophilia News Today
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - Yahoo Finance
ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B - Contemporary Pediatrics
Hemophilia A or B without inhibitors: marstacimab prophylaxis now an FDA-approved option from age 12 - Vera Health
Mixing Test in a Case of Combined Acquired Hemophilia A and Coagulation Factor Deficiency: A Case Report - Cureus
Recurrent Subdural Hematoma Revealing Undiagnosed Mild Hemophilia A and Factor XIII Deficiency in an Elderly Patient - Cureus
Acquired Hemophilia A With Post‐Phlebotomy Compartment Syndrome - Lam - 2025 - Clinical Case Reports - Wiley Online Library
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight - PR Newswire
Denecimig significantly reduced annualized bleeding rate in people with hemophilia A - The Pharma Letter
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program - BioSpace
Newly ID’d F8 mutation could lead to better hemophilia A treatments - Hemophilia News Today
Diffuse alveolar hemorrhage in a child with mild hemophilia A who underwent bone marrow transplantation for thalassemia: a case report - Frontiers
Concizumab-mtci Approved to Treat Hemophilia A/B Without Inhibitors - Hematology Advisor
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia a'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemophiilia a,   hemophiliaa ,   hemopjilia a,   hemohilia a,   hemophhilia a,   hemophiliaa,   hwmophilia a,   hempphilia a,   heophilia a,   hmophilia a,   hemophilua a,   gemophilia a,   hemophulia a,   hemophilis a,   hrmophilia a,   hemopihlia a,   ehmophilia a,   hemophiia a,   hemmophilia a,   hemopholia a,   hemophillia a,   hemophiloa a,   hemphilia a,   hhemophilia a,   hemophilia aa,   hemoohilia a,   hemophili a,   jemophilia a,   hmeophilia a,   hemohpilia a,   hemoophilia a,   hemophikia a,   emophilia a,   hemopilia a,   hemophila a,   hemo[hilia a,   hemophi;ia a,   hemophilia a,   hemophliia a,   hemophiliia a,   hemophilia s,   hemopphilia a,   hemophili aa,   hempohilia a,   hemophilai a,   heomphilia a,   hemophiliaa a,   hemophilia ,   heemophilia a,   he,ophilia a,   hemopgilia a,   henophilia a,   hemophiila a,   hemiphilia a,   hemophlia a
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z